Mid-Size Pharmaceutical Market Projected to Grow at a Steady CAGR during Forecast Period by 2031

The market is expected to register a CAGR of 8.9% during 2023–2031. Greater focus on R&D will likely remain a key trend in the market.

martinalueis martinalueis
Nov 14, 2025 - 10:24
0 2
Mid-Size Pharmaceutical Market Projected to Grow at a Steady CAGR during Forecast Period by 2031
Mid-Size Pharmaceutical Market

The global mid-size pharmaceutical market is on track for significant expansion, with its size projected to reach approximately USD 1,224 billion by 2031, marking a substantial increase from USD 732 billion in 2023. This growth represents a strong Compound Annual Growth Rate (CAGR) of approximately 8.9% over the 2023-2031 period, highlighting the vital role mid-sized firms play in global healthcare innovation and access.

Key Market Drivers Fueling Growth

Several critical factors are accelerating growth across the mid-size pharmaceutical sector:

  • Rising Disease Burden: The increasing geriatric population and the corresponding surge in chronic diseases (e.g., cancer, autoimmune, cardiovascular disorders) drive demand for targeted and specialized therapies.

  • Innovation Focus: Mid-size players are heavily investing in Research & Development (R&D), leading to advancements in drug discovery, biosimilars, and personalized medicine.

  • Policy Support: Favorable government healthcare expenditure, enhanced public health policies, and streamlined regulatory pathways (e.g., expedited FDA approvals) create a conducive business environment.

  • Collaboration Ecosystem: A growing network of healthcare start-ups and strategic collaborations with digital health companies is accelerating product development and commercialization.

Emerging Market Trends

The market is evolving with several notable trends shaping the future landscape:

  • Precision Therapies: A focus on Personalized Medicine and Biologics, concentrating on niche therapeutic areas to meet individual patient needs.

  • Digital Integration: Widespread adoption of AI, machine learning, and real-world data analytics to enhance drug development efficiency and patient outcomes.

  • ESG Alignment: Increasing adherence to Environmental, Social, and Governance (ESG) standards to satisfy regulatory and investor requirements.

  • Geographical Expansion:Emerging markets, particularly the Asia-Pacific region, are opening new revenue streams due to rapid growth and improving healthcare infrastructure.

Download PDF Sample- https://www.theinsightpartners.com/sample/TIPRE00018321 

Opportunities and Regional Dynamics

The sector presents significant opportunities for growth:

  • Portfolio Diversification: Expansion into high-growth areas like biosimilars, specialty drugs, and novel delivery systems.

  • Strategic Growth: Leveraging Mergers and Acquisitions (M&A) for market consolidation and broadening technological capabilities.

  • Regional Capitalization: Focusing on Geographical Expansion, particularly in underpenetrated areas like Asia-Pacific, which is projected to grow at over 6.9% CAGR through 2028.

  • Technological Adoption: Utilizing advancements in biotechnology and digital health to accelerate time-to-market and improve efficacy.

Regional Insights

  • North America: Remains the largest market, underpinned by advanced medical infrastructure, favorable demographics, and high healthcare expenditure.

  • Europe: Characterized by mature markets, stringent regulatory frameworks, and increasing R&D investment.

  • Asia-Pacific: Positioned as the fastest-growing region due to robust industrialization, proactive government health initiatives, and expanding production capabilities.

Market Outlook

The mid-size pharmaceutical market's robust growth is expected to continue. Companies will navigate competitive and regulatory challenges by prioritizing innovation, strategic alliances, and a patient-centric approach. This collective effort will drive an evolving pharmaceutical landscape focused on both breakthrough therapeutic solutions and increased accessibility worldwide.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean| German| Japanese| French| Chinese| Italian| Spanish

Tags: